Tissue biomarkers of breast cancer and their association with conventional pathologic features

British Journal of Cancer

Volumn 108, Issue 2, 2013, Pages 351-360

  Chung, L ^a   Shibli, S ^b   Moore, K ^b   Elder, E E ^c   Boyle, F M ^d   Marsh, D J ^a   Baxter, R C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d Mater Hospital   (Australia)

Author keywords

Breast cancer diagnosis; Mass spectrometry; Proteomics; Tissue biomarkers

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MEMBRANE PROTEIN; PROGESTERONE RECEPTOR; PROTEIN S 100; UBIQUITIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CATION EXCHANGE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTRADUCTAL CARCINOMA; LIQUID CHROMATOGRAPHY; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TISSUE DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN;

EID: 84873723279     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.552     Document Type: Article

References (50)

1. Aebersold R, Anderson L, Caprioli R, Druker B, Hartwell L, Smith R (2005) Perspective: A program to improve protein biomarker discovery for cancer. J Proteome Res 4: 1104-1109. (Pubitemid 41208668)
2. Ambroise C, McLachlan GJ (2002) Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci USA 99: 6562-6566. (Pubitemid 34526172)
3. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD (2004) S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279: 5059-5065. (Pubitemid 38220521)
4. Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ, Selby PJ (2000) Proteomics: New perspectives, new biomedical opportunities. Lancet 356: 1749-1756.
5. Barraclough DL, Platt-Higgins A, de Silva Rudland S, Barraclough R, Winstanley J, West CR, Rudland PS (2009) The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. Am J Pathol 175: 1848-1857.
6. Barraclough DL, Sewart S, Rudland PS, Shoker BS, Sibson DR, Barraclough R, Davies MP (2010) Microarray analysis of suppression subtracted hybridisation libraries identifies genes associated with breast cancer progression. Cell Oncol 32: 87-99.
7. Bray JD, Jelinsky S, Ghatge R, Bray JA, Tunkey C, Saraf K, Jacobsen BM, Richer JK, Brown EL, Winneker RC, Horwitz KB, Lyttle CR (2005) Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells. J Steroid Biochem Mol Biol 97: 328-341. (Pubitemid 41619412)
8. Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D, Valik D, Vyzula R, Vojtesek B, Nenutil R (2008) Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression. Breast Cancer Res 10: R48.
9. Callesen AK, Christensen R, Madsen JS, Vach W, Zapico E, Cold S, Jorgensen PE, Mogensen O, Kruse TA, Jensen ON (2008) Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 22: 291-300. (Pubitemid 351212854)
10. Cheang MC, van de Rijn M, Nielsen TO (2008) Gene expression profiling of breast cancer. AnnüRev Pathol 3: 67-97. (Pubitemid 351492437)
11. Chen C, Seth AK, Aplin AE (2006) Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer. Mol Cancer Res 4: 695-707. (Pubitemid 44683310)
12. Chung L, Nelson AE, Ho KK, Baxter RC (2009) Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes. J Clin Endocrinol Metab 94: 3038-3043.
13. Confalonieri S, Quarto M, Goisis G, Nuciforo P, Donzelli M, Jodice G, Pelosi G, Viale G, Pece S, Di Fiore PP (2009) Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor. Oncogene 28: 2959-2968.
14. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E, Neoptolemos JP, Lemoine NR (2003) Molecular alterations in pancreatic carcinoma: Expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 201: 63-74. (Pubitemid 37121204)
15. Dairkee SH, Sayeed A, Luciani G, Champion S, Meng Z, Jakkula LR, Feiler HS, Gray JW, Moore DH (2009) Immutable functional attributes of histologic grade revealed by context-independent gene expression in primary breast cancer cells. Cancer Res 69: 7826-7834.
16. Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T (1993) The lifetime risk of developing breast cancer. J Natl Cancer Inst 85: 892-897. (Pubitemid 23157129)
17. Filipek A, Jastrzebska B, Nowotny M, Kuznicki J (2002) CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J Biol Chem 277: 28848-28852.
18. Galvao ER, Martins LM, Ibiapina JO, Andrade HM, Monte SJ (2011) Breast cancer proteomics: A review for clinicians. J Cancer Res Clin Oncol 137: 915-925.
19. Gast MC, van Dulken EJ, van Loenen TK, Kingma-Vegter F, Westerga J, Flohil CC, Knol JC, Jimenez CR, van Gils CH, Wessels LF, Schellens JH, Beijnen JH (2009) Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling. Int J Biol Markers 24: 130-141.
20. Goncalves A, Charafe-Jauffret E, Bertucci F, Audebert S, Toiron Y, Esterni B, Monville F, Tarpin C, Jacquemier J, Houvenaeghel G, Chabannon C, Extra JM, Viens P, Borg JP, Birnbaum D (2008) Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes. Mol Cell Proteomics 7: 1420-1433.
21. Guerreiro Da Silva ID, HüYF, Russo IH, Ao X, Salicioni AM, Yang X, Russo J (2000) S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int J Oncol 16: 231-240.
22. Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA (2011) Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat 130: 619-626.
23. Hahn MA, Dickson KA, Jackson S, Clarkson A, Gill AJ, Marsh DJ (2012) The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination. Hum Mol Genet 21: 559-568.
24. Hammond-Martel I, YüH, Affar EB (2011) Roles of ubiquitin signaling in transcription regulation. Cell Signal 24: 410-421.
25. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
26. Jia SQ, NiüZJ, Zhang LH, Zhong XY, Shi T, DüH, Zhang GG, HüY, SüXL, Ji JF (2009) Identification of prognosis-related proteins in advanced gastric cancer by mass spectrometry-based comparative proteomics. J Cancer Res Clin Oncol 135: 403-411.
27. Jiang H, HüH, Tong X, Jiang Q, ZhüH, Zhang S (2012) Calcium-binding protein S100P and cancer: Mechanisms and clinical relevance. J Cancer Res Clin Oncol 138: 1-9.
28. Kopans DB (2011) Just the facts: Mammography saves lives with little if any radiation risk to the mature breast. Health Phys 101: 578-582.
29. Lam FF, Jankova L, Dent OF, Molloy MP, Kwun SY, Clarke C, Chapuis P, Robertson G, Beale P, Clarke S, Bokey EL, Chan C (2010) Identification of distinctive protein expression patterns in colorectal adenoma. Proteomics Clin Appl 4: 60-70.
30. Leong S, Christopherson RI, Baxter RC (2007) Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry. Cell Physiol Biochem 20: 579-590. (Pubitemid 47340618)
31. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Kuick R, Hanash S (2003) Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63: 2649-2657. (Pubitemid 36605209)
32. Mackay A, Jones C, Dexter T, Silva RL, Bulmer K, Jones A, Simpson P, Harris RA, Jat PS, Neville AM, Reis LF, Lakhani SR, O0Hare MJ (2003) cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene 22: 2680-2688. (Pubitemid 36605615)
33. Marenholz I, Heizmann CW, Fritz G (2004) S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322: 1111-1122. (Pubitemid 39164640)
34. Nakagawa T, Huang SK, Martinez SR, Tran AN, Elashoff D, Ye X, Turner RR, Giuliano AE, Hoon DS (2006) Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis. Cancer Res 66: 11825-11830. (Pubitemid 46094194)
35. Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart M, Pritchard K (2012) Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet 379: 432-444.
36. Reis-Filho JS, Pusztai L (2011) Gene expression profiling in breast cancer: Classification, prognostication, and prediction. Lancet 378: 1812-1823.
37. RicolleaüG, Charbonnel C, Lode L, Loussouarn D, Joalland MP, Bogumil R, Jourdain S, Minvielle S, Campone M, Deporte-Fety R, Campion L, Jezequel P (2006) Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors. Proteomics 6: 1963-1975.
38. Sanders ME, Dias EC, XüBJ, Mobley JA, Billheimer D, Roder H, Grigorieva J, Dowsett M, Arteaga CL, Caprioli RM (2008) Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS. J Proteome Res 7: 1500-1507.
39. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS (2006) Calciumdependent and -independent interactions of the S100 protein family. Biochem J 396: 201-214. (Pubitemid 43837235)
40. Scarlett CJ, Smith RC, Saxby A, Nielsen A, Samra JS, Wilson SR, Baxter RC (2006) Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. Gastroenterology 130: 1670-1678. (Pubitemid 43668861)
41. Schor AP, Carvalho FM, Kemp C, Silva ID, Russo J (2006) S100P calciumbinding protein expression is associated with high-risk proliferative lesions of the breast. Oncol Rep 15: 3-6.
42. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neüoncogene. Science 235: 177-182. (Pubitemid 17231334)
43. Srinivas PR, Kramer BS, Srivastava S (2001) Trends in biomarker research for cancer detection. Lancet Oncol 2: 698-704. (Pubitemid 33085816)
44. Terasaka S, Aita Y, Inoue A, Hayashi S, Nishigaki M, Aoyagi K, Sasaki H, Wada-Kiyama Y, Sakuma Y, Akaba S, Tanaka J, Sone H, Yonemoto J, Tanji M, Kiyama R (2004) Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect 112: 773-781. (Pubitemid 38720158)
45. Vucic D, Dixit VM, Wertz IE (2011) Ubiquitylation in apoptosis: A posttranslational modification at the edge of life and death. Nat Rev Mol Cell Biol 12: 439-452.
46. Wang G, Platt-Higgins A, Carroll J, de Silva Rudland S, Winstanley J, Barraclough R, Rudland PS (2006) Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 66: 1199-1207. (Pubitemid 43165991)
47. Wang N, Ma Q, Wang Y, Ma G, Zhai H (2010) CacyBP/SIP expression is involved in the clinical progression of breast cancer. World J Surg 34: 2545-2552.
48. Wen YY, Yang ZQ, Song M, Li BL, Yao XH, Chen XL, Zhao J, LüYY, ZhüJJ, Wang EH (2010) The expression of SIAH1 is downregulated and associated with Bim and apoptosis in human breast cancer tissues and cells. Mol Carcinog 49: 440-449.
49. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T (2007) The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 67: 8633-8642. (Pubitemid 47437439)
50. Zhang K, Yuan K, WüH, Li Q, Wang Y, Chen S, Zhang L, GüH, FüR (2012) Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS. Appl Biochem Biotechnol 166: 753-763.